Zymeworks Inc
NASDAQ:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NASDAQ:ZYME
Watchlist
Price: 13.7 USD -1.23% Market Closed
Market Cap: 973.4m USD
Have any thoughts about
Zymeworks Inc?
Write Note

Zymeworks Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zymeworks Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Zymeworks Inc
NASDAQ:ZYME
Cash from Financing Activities
$55.7m
CAGR 3-Years
85%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$2.4B
CAGR 3-Years
46%
CAGR 5-Years
25%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$6.9B
CAGR 3-Years
N/A
CAGR 5-Years
5%
CAGR 10-Years
-38%
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
-$3.6B
CAGR 3-Years
29%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$1B
CAGR 3-Years
-10%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.3B
CAGR 3-Years
-93%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zymeworks Inc's Cash from Financing Activities?
Cash from Financing Activities
55.7m USD

Based on the financial report for Jun 30, 2024, Zymeworks Inc's Cash from Financing Activities amounts to 55.7m USD.

What is Zymeworks Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-22%

Over the last year, the Cash from Financing Activities growth was 88%. The average annual Cash from Financing Activities growth rates for Zymeworks Inc have been 85% over the past three years , -22% over the past five years .

Back to Top